Brain Scientific Inc.’s (BRSF) Technology Could Be Part of the Solution as New Research Finds that Neurological Consequences of COVID-19 Could be the Norm Rather than Exception
It has become known that COVID-19 patients can present with neurological symptoms, but new comprehensive cross-country study indicates that it could be more prevalent than previously thought This could represent enormous challenge to healthcare as it needs to prepare for immediate and longer-term rehabilitation care of these patients Brain Scientific is committed to remaining at forefront of brain diagnostics, potentially offering solution to higher need for neurological care of COVID-19 patients Brain Scientific (OTCQB: BRSF), a commercial-stage health care company on a mission to modernize brain diagnostics, could be the one offering solution to the rising challenge global healthcare systems…